Page last updated: 2024-12-11

1-palmitoyl-2-((2-(4-(6-phenyl-1,3,4-hexatrienyl)phenyl)ethyl)carbonyl)-3-phosphatidylcholine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

1-palmitoyl-2-((2-(4-(6-phenyl-1,3,4-hexatrienyl)phenyl)ethyl)carbonyl)-3-phosphatidylcholine, often abbreviated as **1-Pal-2-(PE-Ph-Hex)-PC**, is a **synthetic lipid analog** with a unique structure. Here's a breakdown of its components and significance:

**Structure:**

* **1-Palmitoyl:** Indicates a palmitic acid (a saturated fatty acid) is attached to the first carbon of the glycerol backbone.
* **2-((2-(4-(6-phenyl-1,3,4-hexatrienyl)phenyl)ethyl)carbonyl):** This is the key modification. It introduces a long, conjugated, phenyl-containing chain, resembling a **photosensitive molecule**, attached to the second carbon of the glycerol backbone via an ester bond.
* **3-Phosphatidylcholine:** This denotes the presence of a phosphate group (PO4) and a choline molecule attached to the third carbon of the glycerol backbone. This is the standard head group of phosphatidylcholine, a major phospholipid in cell membranes.

**Importance in Research:**

1-Pal-2-(PE-Ph-Hex)-PC is primarily important for research due to its **photosensitive nature**. The extended conjugated system within its structure allows it to **absorb light** and undergo **photoisomerization**. This photo-induced conformational change can be used to study:

* **Lipid membrane dynamics:** By incorporating this lipid analog into model membranes or liposomes, researchers can use light to manipulate the membrane structure and fluidity. This allows studying the effects of membrane fluidity on various processes like protein function, drug delivery, and cell signaling.
* **Photo-switchable interactions:** The photosensitive nature of 1-Pal-2-(PE-Ph-Hex)-PC can be utilized to control interactions with other molecules. For example, it can be used to create light-activated drug delivery systems or to manipulate the activity of membrane-associated enzymes.
* **Membrane organization:** The unique structure of this lipid can be used to study membrane organization and lipid clustering. By analyzing the behavior of 1-Pal-2-(PE-Ph-Hex)-PC in model membranes, researchers can gain insights into the organization and dynamics of biological membranes.

**Key Applications:**

* **Development of photo-controlled drug delivery systems:** The photosensitive nature of 1-Pal-2-(PE-Ph-Hex)-PC allows for controlled release of drugs upon light irradiation.
* **Probing membrane dynamics:** This lipid analog can be used as a probe to study membrane fluidity, lateral diffusion, and phase transitions in model membranes.
* **Creating photo-switchable biological systems:** Researchers are investigating the use of 1-Pal-2-(PE-Ph-Hex)-PC to engineer photo-switchable proteins and other biological systems.

**Overall, 1-Pal-2-(PE-Ph-Hex)-PC is a valuable tool for researchers studying lipid membrane dynamics, photo-controlled biological processes, and the development of novel technologies in areas such as drug delivery and biosensing.**

1-palmitoyl-2-((2-(4-(6-phenyl-1,3,4-hexatrienyl)phenyl)ethyl)carbonyl)-3-phosphatidylcholine: RN given from first source; RN given refers to (trans)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID6439934
MeSH IDM0138062

Synonyms (13)

Synonym
dph-pc
117142-43-5
2-(3-(diphenylhexatrienyl)propanoyl)-3-palmitoylphosphatidylcholine
3,5,9-trioxa-4-phosphapentacosan-1-aminium, 4-hydroxy-n,n,n-trimethyl-10-oxo-7-(1-oxo-4-(4-(6-phenyl-1,3,5-hexatrienyl)phenyl)butoxy)-, hydroxide, inner salt, 4-oxide, (r)-
dphppc
1-palmitoyl-2-[3-(diphenylhexatriene)propanoyl]-sn-phosphatidylcholine
2-(3-(diphenylhexatrienyl)propanoyl)-1-hexadecanoyl-sn-glycero-3-phosphocholine
[(2r)-3-hexadecanoyloxy-2-[3-[4-[(1e,3e,5e)-6-phenylhexa-1,3,5-trienyl]phenyl]propanoyloxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate
1-palmitoyl-2-((2-(4-(6-phenyl-1,3,4-hexatrienyl)phenyl)ethyl)carbonyl)-3-phosphatidylcholine
3,5,9-trioxa-4-phosphapentacosan-1-aminium, 4-hydroxy-n,n,n-trimethyl-10-oxo-7-(1-oxo-3-(4-(6-phenyl-1,3,5-hexatrienyl)phenyl)propoxy)-, hydroxide, inner salt, 4-oxide, (r-(e,e,e))-
98014-38-1
CS-0031962
HY-W020798
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (28)

TimeframeStudies, This Drug (%)All Drugs %
pre-19906 (21.43)18.7374
1990's17 (60.71)18.2507
2000's4 (14.29)29.6817
2010's1 (3.57)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.17

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.17 (24.57)
Research Supply Index3.40 (2.92)
Research Growth Index4.57 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.17)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other29 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]